| US6113855A (en)* | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US7914994B2 (en)* | 1998-12-24 | 2011-03-29 | Cepheid | Method for separating an analyte from a sample |
| US6319719B1 (en)* | 1999-10-28 | 2001-11-20 | Roche Diagnostics Corporation | Capillary hematocrit separation structure and method |
| JP2003524193A (en)* | 2000-02-23 | 2003-08-12 | ザイオミックス インコーポレイテッド | Chip with sample surface positioned high |
| US7981420B2 (en) | 2000-12-22 | 2011-07-19 | Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. | Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| US7713705B2 (en)* | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| US7632647B2 (en)* | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| US20040126767A1 (en)* | 2002-12-27 | 2004-07-01 | Biosite Incorporated | Method and system for disease detection using marker combinations |
| US7524635B2 (en)* | 2003-04-17 | 2009-04-28 | Biosite Incorporated | Methods and compositions for measuring natriuretic peptides and uses thereof |
| US20030199000A1 (en)* | 2001-08-20 | 2003-10-23 | Valkirs Gunars E. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20030219734A1 (en)* | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US20040253637A1 (en)* | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US20040203083A1 (en)* | 2001-04-13 | 2004-10-14 | Biosite, Inc. | Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases |
| US20040121350A1 (en)* | 2002-12-24 | 2004-06-24 | Biosite Incorporated | System and method for identifying a panel of indicators |
| US6759009B2 (en) | 2001-05-04 | 2004-07-06 | Portascience Incorporated | Method and device for clotting time assay |
| AU2002305394A1 (en) | 2001-05-04 | 2002-11-18 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| US20040219509A1 (en)* | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| EP1419388B1 (en)* | 2001-08-20 | 2009-10-07 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US6919058B2 (en)* | 2001-08-28 | 2005-07-19 | Gyros Ab | Retaining microfluidic microcavity and other microfluidic structures |
| CA2471925A1 (en)* | 2002-01-04 | 2003-07-24 | Peter R.C. Gascoyne | Wall-less channels for fluidic routing and confinement |
| US7459127B2 (en)* | 2002-02-26 | 2008-12-02 | Siemens Healthcare Diagnostics Inc. | Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces |
| US7223368B2 (en) | 2002-05-03 | 2007-05-29 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
| US7223534B2 (en) | 2002-05-03 | 2007-05-29 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
| US7214530B2 (en)* | 2002-05-03 | 2007-05-08 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices |
| US7485453B2 (en)* | 2002-05-03 | 2009-02-03 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
| US7771922B2 (en) | 2002-05-03 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic device |
| US7118855B2 (en)* | 2002-05-03 | 2006-10-10 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
| US7091049B2 (en) | 2002-06-26 | 2006-08-15 | Kimberly-Clark Worldwide, Inc. | Enhanced diffraction-based biosensor devices |
| KR100480338B1 (en)* | 2002-08-08 | 2005-03-30 | 한국전자통신연구원 | Microfluidic devices for the controlled movements of solution |
| US7169550B2 (en)* | 2002-09-26 | 2007-01-30 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
| KR100444751B1 (en)* | 2002-11-11 | 2004-08-16 | 한국전자통신연구원 | Device of Controlling Fluid using Surface Tension |
| JP4253178B2 (en)* | 2002-12-02 | 2009-04-08 | アークレイ株式会社 | Method for manufacturing analytical tool |
| US7094354B2 (en) | 2002-12-19 | 2006-08-22 | Bayer Healthcare Llc | Method and apparatus for separation of particles in a microfluidic device |
| US7125711B2 (en) | 2002-12-19 | 2006-10-24 | Bayer Healthcare Llc | Method and apparatus for splitting of specimens into multiple channels of a microfluidic device |
| US7341838B2 (en) | 2003-04-17 | 2008-03-11 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US7435381B2 (en)* | 2003-05-29 | 2008-10-14 | Siemens Healthcare Diagnostics Inc. | Packaging of microfluidic devices |
| US7347617B2 (en) | 2003-08-19 | 2008-03-25 | Siemens Healthcare Diagnostics Inc. | Mixing in microfluidic devices |
| US7582472B2 (en)* | 2003-08-26 | 2009-09-01 | Smith Kenneth E | Apparatus and method for liquid sample testing |
| CA2537668A1 (en)* | 2003-09-29 | 2005-04-14 | Biosite Incorporated | Methods and compositions for the diagnosis of sepsis |
| DE10354806A1 (en)* | 2003-11-21 | 2005-06-02 | Boehringer Ingelheim Microparts Gmbh | sample carrier |
| DE10360220A1 (en)* | 2003-12-20 | 2005-07-21 | Steag Microparts Gmbh | Fine structure arrangement in fluid ejection system, has predetermined region in transitional zone between inlet and discharge ports, at which capillary force is maximum |
| WO2005095967A1 (en)* | 2004-03-23 | 2005-10-13 | Quidel Corporation | Hybrid phase lateral flow assay |
| SE0400662D0 (en)* | 2004-03-24 | 2004-03-24 | Aamic Ab | Assay device and method |
| US20060105419A1 (en)* | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
| JP2007523355A (en)* | 2004-08-21 | 2007-08-16 | エルジー・ライフ・サイエンシズ・リミテッド | Microfluidic device and diagnostic and analytical apparatus including the same |
| EP1794588A2 (en)* | 2004-09-09 | 2007-06-13 | Biosite Incorporated | Methods and compositions for measuring canine bnp and uses thereof |
| US20080050832A1 (en)* | 2004-12-23 | 2008-02-28 | Buechler Kenneth F | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| US7879979B2 (en)* | 2005-01-21 | 2011-02-01 | Alere International | Arginine analogs, and methods for their synthesis and use |
| US7611908B2 (en) | 2005-05-02 | 2009-11-03 | Bioscale, Inc. | Method and apparatus for therapeutic drug monitoring using an acoustic device |
| US7300631B2 (en) | 2005-05-02 | 2007-11-27 | Bioscale, Inc. | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
| US7749445B2 (en) | 2005-05-02 | 2010-07-06 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
| US7648844B2 (en) | 2005-05-02 | 2010-01-19 | Bioscale, Inc. | Method and apparatus for detection of analyte using an acoustic device |
| US20070269836A1 (en)* | 2005-06-09 | 2007-11-22 | Mcpherson Paul H | Methods and compositions for the diagnosis of venous thromboembolic disease |
| WO2007028070A2 (en)* | 2005-08-30 | 2007-03-08 | Biosite, Inc. | Use of soluble flt-1 and its fragments in cardiovascular conditions |
| ES2542501T3 (en) | 2005-09-30 | 2015-08-06 | Abbvie Deutschland Gmbh & Co Kg | Protein binding domains of the protein family of repulsive targeting molecules (RGM) and functional fragments thereof, as well as their use |
| US8133741B2 (en) | 2005-10-26 | 2012-03-13 | General Electric Company | Methods and systems for delivery of fluidic samples to sensor arrays |
| US7723120B2 (en)* | 2005-10-26 | 2010-05-25 | General Electric Company | Optical sensor array system and method for parallel processing of chemical and biochemical information |
| US7871568B2 (en) | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
| US7794656B2 (en) | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
| EP2005168A4 (en)* | 2006-03-09 | 2009-05-20 | Biosite Inc | Methods and compositions for the diagnosis of diseases of the aorta |
| US20080118924A1 (en)* | 2006-05-26 | 2008-05-22 | Buechler Kenneth F | Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
| GB0611116D0 (en) | 2006-06-06 | 2006-07-19 | Oxford Genome Sciences Uk Ltd | Proteins |
| ATE528411T1 (en) | 2006-06-07 | 2011-10-15 | Otago Innovation Ltd | DIAGNOSTIC METHODS AND MARKERS |
| WO2008094198A2 (en)* | 2006-07-28 | 2008-08-07 | Biosite Incorporated | Devices and methods for performing receptor binding assays using magnetic particles |
| EP2089722B1 (en) | 2006-09-07 | 2017-11-08 | Otago Innovation Limited | Biomarker for early detection of acute cardiac disorders |
| EP2095106B1 (en)* | 2006-11-14 | 2013-03-20 | Alere San Diego, Inc. | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
| EP2095107B1 (en) | 2006-11-14 | 2014-07-02 | Alere San Diego, Inc. | Methods for risk assignment |
| US20080118402A1 (en)* | 2006-11-21 | 2008-05-22 | David Brancazio | Method and apparatus for analyte processing |
| US8202491B2 (en) | 2006-11-21 | 2012-06-19 | Bioscale, Inc. | Apparatus for analyte processing |
| US20090004755A1 (en)* | 2007-03-23 | 2009-01-01 | Biosite, Incorporated | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| US8221995B2 (en)* | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| EP1977829A1 (en)* | 2007-03-29 | 2008-10-08 | Roche Diagnostics GmbH | Device for performing multiple analyses in parallel |
| US7883898B2 (en)* | 2007-05-07 | 2011-02-08 | General Electric Company | Method and apparatus for measuring pH of low alkalinity solutions |
| US20080295909A1 (en)* | 2007-05-24 | 2008-12-04 | Locascio Laurie E | Microfluidic Device for Passive Sorting and Storage of Liquid Plugs Using Capillary Force |
| WO2009033056A1 (en) | 2007-09-06 | 2009-03-12 | Bioscale, Inc. | Reusable detection surfaces and methods of using same |
| WO2009034563A2 (en) | 2007-09-14 | 2009-03-19 | Nanocomms Patents Limited | An analysis system |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| AU2009224113B2 (en) | 2008-03-12 | 2013-02-21 | Otago Innovation Limited | Biomarkers |
| WO2009113880A1 (en) | 2008-03-12 | 2009-09-17 | Christopher Joseph Pemberton | Biomarkers |
| SE533514C2 (en)* | 2008-06-16 | 2010-10-12 | Aamic Ab | Analytical apparatus and method |
| CN105067819B (en) | 2008-08-28 | 2018-05-22 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2813848A3 (en) | 2008-08-29 | 2015-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2172260A1 (en)* | 2008-09-29 | 2010-04-07 | Corning Incorporated | Multiple flow path microfluidic devices |
| NZ607703A (en) | 2008-10-21 | 2014-09-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2010048347A2 (en) | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| BRPI0922021A2 (en) | 2008-11-10 | 2019-09-24 | Astute Medical Inc | method for assessing kidney condition in an individual, and use of one or more markers of kidney injury |
| CN104034901A (en) | 2008-11-22 | 2014-09-10 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US20100204055A1 (en)* | 2008-12-05 | 2010-08-12 | Bonner-Ferraby Phoebe W | Autoantibody detection systems and methods |
| US20100143194A1 (en)* | 2008-12-08 | 2010-06-10 | Electronics And Telecommunications Research Institute | Microfluidic device |
| JP2012517594A (en) | 2009-02-06 | 2012-08-02 | アスチュート メディカル,インコーポレイテッド | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA2751430A1 (en) | 2009-02-06 | 2010-08-12 | Astute Medical, Inc. | Diagnosis and prognosis of renal injury and renal failure |
| US9752191B2 (en) | 2009-07-09 | 2017-09-05 | The Scripps Research Institute | Gene expression profiles associated with chronic allograft nephropathy |
| NZ598035A (en) | 2009-08-07 | 2014-06-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN102576011B (en) | 2009-08-07 | 2014-09-17 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA2772336A1 (en) | 2009-08-28 | 2011-03-03 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| NZ598741A (en) | 2009-09-18 | 2013-07-26 | Astute Medical Inc | Methods and composition for diagnosis and prognosis of renal injury and renal failure by performing assays to detect metalloproteinase inhibitor 4 on a body fluid sample |
| NZ630277A (en) | 2009-09-21 | 2015-02-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EA201290192A1 (en) | 2009-11-07 | 2013-02-28 | Астьют Медикал, Инк. | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF KIDNEY DAMAGE AND RENAL FAILURE |
| NZ624614A (en) | 2009-11-07 | 2015-10-30 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| DK2510001T3 (en) | 2009-12-08 | 2016-02-29 | Abbvie Deutschland | MONOCLONAL ANTIBODIES AGAINST RGM A PROTEIN USED TO TREAT DEGENERATION OF THE RETINAL NERVE FIBER LAYER |
| EP3112871B1 (en) | 2009-12-20 | 2020-07-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| MX366653B (en) | 2010-02-05 | 2019-07-17 | Astute Medical Inc | METHODS and COMPOSITIONS FOR DIAGNOSIS and PROGNOSIS OF RENAL INJURY and RENAL FAILURE. |
| CA2789147A1 (en) | 2010-02-05 | 2011-08-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN102884205B (en) | 2010-02-05 | 2016-05-04 | 阿斯图特医药公司 | Be used for the method and composition of the diagnosis and prognostic of injury of kidney and kidney failure |
| WO2011162819A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2011162820A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2012048082A2 (en) | 2010-10-07 | 2012-04-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| AU2011220413B2 (en) | 2010-02-26 | 2015-07-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US9199232B2 (en) | 2010-04-07 | 2015-12-01 | Biosensia Patents Limited | Flow control device for assays |
| JP5786020B2 (en) | 2010-04-16 | 2015-09-30 | アボットジャパン株式会社 | Methods and reagents for diagnosing rheumatoid arthritis |
| EP2585827A4 (en) | 2010-06-23 | 2013-12-04 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE |
| DK2596010T3 (en) | 2010-07-19 | 2017-07-31 | Otago Innovation Ltd | SIGNAL biomarkers |
| JP2013541005A (en) | 2010-09-24 | 2013-11-07 | アスチュート メディカル,インコーポレイテッド | Methods and compositions for the assessment of renal injury using hyaluronic acid |
| US10557856B2 (en) | 2010-09-24 | 2020-02-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biomarkers of renal injury |
| EP2646822B1 (en) | 2010-11-29 | 2017-11-01 | Alere San Diego, Inc. | Methods for diagnosis and risk prediction in heart failure |
| EP2661626B1 (en) | 2011-01-08 | 2016-06-01 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2668497B1 (en) | 2011-01-26 | 2020-03-25 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Urine biomarkers for prediction of recovery after acute kidney injury : proteomics |
| EP2668499A4 (en) | 2011-01-29 | 2015-05-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3489690A1 (en) | 2011-08-26 | 2019-05-29 | Astute Medical, Inc. | Methods and compositions for evaluation of the renal status |
| IN2014MN00949A (en) | 2011-11-22 | 2015-04-24 | Astute Medical Inc | |
| EP2788759B1 (en) | 2011-12-08 | 2019-02-20 | Astute Medical, Inc. | Methods and uses for diagnosis of renal injury and renal failure |
| WO2013090633A2 (en) | 2011-12-14 | 2013-06-20 | AbbVie Deutschland GmbH & Co. KG | Composition and method for the diagnosis and treatment of iron-related disorders |
| CA2855840C (en) | 2011-12-14 | 2023-08-29 | AbbVie Deutschland GmbH & Co. KG | Composition and method for the diagnosis and treatment of iron-related disorders |
| BR102013001328A2 (en) | 2012-01-20 | 2015-05-12 | Ortho Clinical Diagnostics Inc | Teaching device having uniform flow near corners |
| MX352772B (en) | 2012-01-27 | 2017-12-07 | Abbvie Deutschland | Composition and method for diagnosis and treatment of diseases associated with neurite degeneration. |
| JP6538353B2 (en) | 2012-02-27 | 2019-07-03 | アスチュート メディカル,インコーポレイテッド | Methods and compositions for diagnosis and prognosis of kidney injury and failure |
| CA2866220A1 (en) | 2012-03-13 | 2013-09-19 | Abbvie Inc. | Method for selecting or identifying a subject for v1b antagonist therapy |
| CN104470942B (en) | 2012-03-20 | 2018-12-14 | 奥塔哥创新有限公司 | Biomarker |
| EP3699591A1 (en) | 2012-04-02 | 2020-08-26 | Astute Medical, Inc. | Methods for diagnosis and prognosis of sepsis |
| WO2013163345A1 (en) | 2012-04-24 | 2013-10-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury |
| US20150177260A1 (en) | 2012-07-23 | 2015-06-25 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of sepsis |
| US10081842B2 (en) | 2012-08-07 | 2018-09-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer gene expression profiles |
| US20150241415A1 (en) | 2012-08-11 | 2015-08-27 | Astute Medical, Inc. | Evaluating renal injury using hyaluronic acid |
| CA3129014A1 (en)* | 2012-11-15 | 2014-05-15 | Ortho-Clinical Diagnostics, Inc. | Quality/process control of a lateral flow assay device based on flow monitoring |
| EP2925884B1 (en) | 2012-11-27 | 2018-01-31 | Luxembourg Institute of Health | Compositions and methods for evaluating heart failure |
| ES2681955T3 (en) | 2013-01-17 | 2018-09-17 | Astute Medical, Inc. | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
| WO2014152657A1 (en) | 2013-03-14 | 2014-09-25 | Alere San Diego, Inc. | 6-acetylmorphine analogs, and methods for their synthesis and use |
| US9469686B2 (en) | 2013-03-15 | 2016-10-18 | Abbott Laboratories | Anti-GP73 monoclonal antibodies and methods of obtaining the same |
| EP3004873B1 (en) | 2013-06-05 | 2024-01-24 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3003372B1 (en) | 2013-06-07 | 2019-10-09 | Duke University | Inhibitors of complement factor h |
| KR20160039682A (en) | 2013-08-07 | 2016-04-11 | 아스튜트 메디컬 인코포레이티드 | Assays for timp2 having improved performance in biological samples |
| SG11201601202WA (en) | 2013-08-23 | 2016-03-30 | Reata Pharmaceuticals Inc | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof |
| WO2015031626A1 (en) | 2013-08-28 | 2015-03-05 | Abbvie Inc. | Soluble cmet assay |
| WO2015179773A1 (en) | 2014-05-22 | 2015-11-26 | The Scripps Research Institute | Tissue molecular signatures of kidney transplant rejections |
| EP3047270A4 (en) | 2013-09-20 | 2017-07-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain |
| BR112016010106A2 (en) | 2013-11-06 | 2017-12-05 | Astute Medical Inc | best performing igfbp7 assays on biological samples |
| CN110007084B (en) | 2013-12-03 | 2022-11-18 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3090067B1 (en) | 2013-12-30 | 2020-07-22 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Genomic rearrangements associated with prostate cancer and methods of using the same |
| WO2015179771A2 (en) | 2014-05-22 | 2015-11-26 | The Scripps Research Institute | Molecular signatures for distinguishing liver transplant rejections or injuries |
| WO2015179777A2 (en) | 2014-05-22 | 2015-11-26 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
| US11104951B2 (en) | 2014-05-22 | 2021-08-31 | The Scripps Research Institute | Molecular signatures for distinguishing liver transplant rejections or injuries |
| US10443100B2 (en) | 2014-05-22 | 2019-10-15 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
| MX388231B (en) | 2014-10-20 | 2025-03-19 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF KIDNEY INJURY AND KIDNEY FAILURE. |
| WO2016100912A1 (en) | 2014-12-18 | 2016-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3281011B1 (en) | 2015-04-09 | 2024-06-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| HK1249467A1 (en) | 2015-05-12 | 2018-11-02 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| HK1248808A1 (en) | 2015-06-11 | 2018-10-19 | 阿斯图特医药公司 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US20180224466A1 (en) | 2015-06-17 | 2018-08-09 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain |
| WO2017011329A1 (en) | 2015-07-10 | 2017-01-19 | West Virginia University | Markers of stroke and stroke severity |
| EP3458439B1 (en) | 2016-05-18 | 2021-12-08 | Alere San Diego, Inc. | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use |
| US11243217B2 (en) | 2016-06-06 | 2022-02-08 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
| NL2017267B1 (en) | 2016-07-29 | 2018-02-01 | Aduro Biotech Holdings Europe B V | Anti-pd-1 antibodies |
| AU2017339809B2 (en) | 2016-10-03 | 2022-02-17 | Abbott Laboratories | Improved methods of assessing UCH-L1 status in patient samples |
| EP3522893B1 (en) | 2016-10-04 | 2024-12-04 | University Of Maryland, Baltimore | Methods of treating sepsis using anti-sepsis lipid a (asla) based therapeutics |
| JP6633812B2 (en) | 2016-11-08 | 2020-01-22 | リアタ ファーマシューティカルズ インコーポレイテッド | Method of treating alport syndrome using bardoxolone methyl or analogs thereof |
| US11353465B2 (en) | 2017-01-12 | 2022-06-07 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement |
| CN110678751A (en) | 2017-03-09 | 2020-01-10 | 克利拉生物技术有限公司 | Biomarkers for cellular senescence |
| JP7346300B2 (en) | 2017-03-23 | 2023-09-19 | アボット・ラボラトリーズ | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in human subjects using the early biomarker ubiquitin carboxy-terminal hydrolase L1 |
| CN110546513A (en) | 2017-04-15 | 2019-12-06 | 雅培实验室 | Method for aiding hyperacute diagnosis and determination of traumatic brain injury in human subjects using early biomarkers |
| CN110603449A (en) | 2017-04-28 | 2019-12-20 | 雅培实验室 | Method for determining traumatic brain injury using early biomarkers from at least two samples of the same human subject for aiding hyperacute diagnosis |
| US10865238B1 (en) | 2017-05-05 | 2020-12-15 | Duke University | Complement factor H antibodies |
| CN110753700A (en) | 2017-05-07 | 2020-02-04 | 机敏医药股份有限公司 | Use of insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy |
| CN110651190A (en) | 2017-05-25 | 2020-01-03 | 雅培实验室 | Method for using early biomarkers to help determine whether to perform imaging on a human subject who has suffered or may have suffered a head injury |
| AU2018275236B2 (en) | 2017-05-30 | 2024-11-07 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I |
| EP3649474A1 (en) | 2017-07-03 | 2020-05-13 | Abbott Laboratories | Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood |
| JP7379165B2 (en) | 2017-12-09 | 2023-11-14 | アボット・ラボラトリーズ | Methods for aiding in diagnosing and assessing traumatic brain injury in human subjects using a combination of GFAP and UCH-L1 |
| CN111094983A (en) | 2017-12-09 | 2020-05-01 | 雅培实验室 | Methods of using Glial Fibrillary Acidic Protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1(UCH-L1) to aid in the diagnosis and evaluation of patients who have suffered orthopedic injury and who have suffered or may have suffered a head injury such as mild Traumatic Brain Injury (TBI) |
| US11891439B2 (en) | 2017-12-28 | 2024-02-06 | Astute Medical, Inc. | Antibodies and assays for CCL14 |
| BR112020010430A2 (en) | 2017-12-29 | 2020-11-24 | Abbott Laboratories | biomarkers and innovative methods to diagnose and evaluate traumatic brain injury |
| CN112119151B (en) | 2018-03-02 | 2025-08-29 | 量子细胞公司 | Methods, compositions and devices for isolating and analyzing regions of interest from tissues for expression analysis |
| US12235273B2 (en) | 2018-05-04 | 2025-02-25 | Abbott Laboratories | HBV diagnostic, prognostic, and therapeutic methods and products |
| EP4043015A1 (en) | 2018-09-04 | 2022-08-17 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Delta-tocotrienol for treating cancer |
| JP7493513B2 (en) | 2018-12-28 | 2024-05-31 | アボット・ラボラトリーズ | Direct detection of single molecules on microparticles |
| WO2020144535A1 (en) | 2019-01-08 | 2020-07-16 | Aduro Biotech Holdings, Europe B.V. | Methods and compositions for treatment of multiple myeloma |
| WO2020180695A1 (en) | 2019-03-01 | 2020-09-10 | Abbott Laboratories | Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease |
| CA3132338A1 (en) | 2019-04-05 | 2020-10-08 | David Suhy | Improved methods and compositions for synthetic biomarkers |
| EP4136459A1 (en) | 2020-04-13 | 2023-02-22 | Abbott Laboratories | Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample |
| IL298008A (en) | 2020-05-09 | 2023-01-01 | Reata Pharmaceuticals Holdings Llc | Methods of treating covid-19 using bardoxolone methyl or analogs thereof |
| BR112022022986A2 (en) | 2020-05-13 | 2023-01-17 | Disc Medicine Inc | ANTI-HEMOJUVELIN (HJV) ANTIBODIES TO TREAT MYELOFIBROSIS |
| MX2022015287A (en) | 2020-06-01 | 2023-02-22 | Loop Diagnostics S L | Method and kit for the early detection of sepsis. |
| KR20230042301A (en) | 2020-08-04 | 2023-03-28 | 애벗트 라보라토리이즈 | Improved methods and kits for detecting SARS-COV-2 proteins in samples |
| WO2022029494A1 (en) | 2020-08-04 | 2022-02-10 | Abbott Rapid Diagnostics International Unlimited Company | Assays for detecting sars-cov-2 |
| US20220170948A1 (en) | 2020-12-01 | 2022-06-02 | Abbott Laboratories | Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi |
| WO2023102384A1 (en) | 2021-11-30 | 2023-06-08 | Abbott Laboratories | Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi |
| EP4259155A1 (en) | 2020-12-11 | 2023-10-18 | Reata Pharmaceuticals Holdings, LLC | Synthetic triterpenoids for use in therapy |
| WO2022147147A1 (en) | 2020-12-30 | 2022-07-07 | Abbott Laboratories | Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample |
| JP2024519858A (en) | 2021-05-18 | 2024-05-21 | アボット・ラボラトリーズ | Methods for assessing brain injury in pediatric subjects |
| JP2024521476A (en) | 2021-06-14 | 2024-05-31 | アボット・ラボラトリーズ | Methods for diagnosing or aiding in the diagnosis of brain injury caused by acoustic energy, electromagnetic energy, overpressure waves and/or blast waves |
| EP4392783A1 (en) | 2021-08-27 | 2024-07-03 | Abbott Laboratories | Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample |
| CN118715440A (en) | 2021-08-31 | 2024-09-27 | 雅培实验室 | Method and system for diagnosing brain injury |
| CA3230038A1 (en) | 2021-08-31 | 2023-03-09 | Hongwei Zhang | Methods and systems of diagnosing brain injury |
| WO2023056268A1 (en) | 2021-09-30 | 2023-04-06 | Abbott Laboratories | Methods and systems of diagnosing brain injury |
| CA3240822A1 (en) | 2021-12-17 | 2023-06-22 | Tony Lee | Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples |
| WO2023144206A1 (en) | 2022-01-27 | 2023-08-03 | Sanofi Pasteur | Modified vero cells and methods of using the same for virus production |
| AU2023216317A1 (en) | 2022-02-04 | 2024-09-05 | Abbott Laboratories | Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample |
| AU2023260822A1 (en) | 2022-04-29 | 2024-11-14 | Broadwing Bio Llc | Complement factor h related 4-specific antibodies and uses thereof |
| CN119487063A (en) | 2022-04-29 | 2025-02-18 | 博闻生物有限责任公司 | Bispecific antibodies and methods for treating eye diseases |
| KR20250021399A (en) | 2022-04-29 | 2025-02-12 | 브로드윙 바이오 엘엘씨 | Angiopoietin-related protein 7-specific antibodies and uses thereof |
| EP4587842A1 (en) | 2022-09-15 | 2025-07-23 | Abbott Laboratories | Biomarkers and methods for differentiating between mild and supermild traumatic brain injury |
| KR20250068724A (en) | 2022-09-15 | 2025-05-16 | 아보트 러보러터리즈 | HBV diagnostic, prognostic and therapeutic methods and products |
| WO2024163477A1 (en) | 2023-01-31 | 2024-08-08 | University Of Rochester | Immune checkpoint blockade therapy for treating staphylococcus aureus infections |
| WO2024211475A1 (en) | 2023-04-04 | 2024-10-10 | Abbott Laboratories | Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi) |
| WO2024227154A1 (en) | 2023-04-28 | 2024-10-31 | Broadwing Bio Llc | Complement component 3 (c3)-specific antibodies and uses thereof |
| WO2024226969A1 (en) | 2023-04-28 | 2024-10-31 | Abbott Point Of Care Inc. | Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers |
| US12122842B1 (en) | 2023-09-27 | 2024-10-22 | R&D Systems, Inc. | Human CD30-specific binding proteins and uses thereof |
| WO2025111147A1 (en) | 2023-11-21 | 2025-05-30 | Abbott Laboratories | Two-dimensional matrix droplet array |